Antipodean Advisors LLC - Q2 2014 holdings

$1.34 Billion is the total value of Antipodean Advisors LLC's 21 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 94.1% .

 Value Shares↓ Weighting
LNG SellCHENIERE ENERGY INC$172,725,000
+24.4%
2,409,000
-4.0%
12.90%
-0.4%
VRX BuyVALEANT PHARMACEUTICALS INTL$146,955,000
+30.7%
1,165,200
+36.6%
10.98%
+4.6%
WAG  WALGREEN CO$144,035,000
+12.3%
1,943,0000.0%10.76%
-10.1%
WDAY BuyWORKDAY INCcl a$105,963,000
+25.2%
1,179,205
+27.3%
7.92%
+0.2%
STZ SellCONSTELLATION BRANDS INCcl a$104,346,000
-12.3%
1,184,000
-15.4%
7.80%
-29.8%
SNDK NewSANDISK CORP$102,759,000984,000
+100.0%
7.68%
MU NewMICRON TECHNOLOGY INC$94,534,0002,869,000
+100.0%
7.06%
CHTR BuyCHARTER COMMUNICATIONS INC Dcl a new$89,190,000
+51.1%
563,142
+17.5%
6.66%
+21.0%
ENDP SellENDO INTL PLC$73,941,000
-3.0%
1,056,000
-4.9%
5.52%
-22.3%
ILMN SellILLUMINA INC$73,469,000
+14.6%
411,500
-4.6%
5.49%
-8.3%
RL NewRALPH LAUREN CORPcl a$48,368,000301,000
+100.0%
3.61%
HRB SellBLOCK H & R INC$37,082,000
-33.4%
1,106,273
-40.0%
2.77%
-46.7%
NFLX NewNETFLIX INC$31,723,00072,000
+100.0%
2.37%
NRF SellNORTHSTAR RLTY FIN CORP$30,172,000
-54.6%
1,736,000
-57.9%
2.25%
-63.7%
DATA NewTABLEAU SOFTWARE INCcl a$25,108,000352,000
+100.0%
1.88%
MDLZ NewMONDELEZ INTL INCcl a$19,933,000530,000
+100.0%
1.49%
AZN NewASTRAZENECA PLCsponsored adr$19,766,000266,000
+100.0%
1.48%
RAD NewRITE AID CORP$10,913,0001,522,000
+100.0%
0.82%
SHLDQ SellSEARS HLDGS CORP$5,275,000
-61.2%
132,000
-53.7%
0.39%
-69.0%
CSLT NewCASTLIGHT HEALTH INCcl b$1,155,00076,000
+100.0%
0.09%
SODA NewSODASTREAM INTERNATIONAL LTD$1,109,00033,000
+100.0%
0.08%
UNIS ExitUNILIFE CORP NEW$0-1,784,000
-100.0%
-0.68%
BOFI ExitBOFI HLDG INC$0-140,000
-100.0%
-1.12%
ZU ExitZULILY INCcl a$0-366,383
-100.0%
-1.72%
CBS ExitCBS CORP NEWcl b$0-394,000
-100.0%
-2.27%
JCPNQ ExitPENNEY J C INC$0-3,171,000
-100.0%
-2.55%
LNKD ExitLINKEDIN CORP$0-345,400
-100.0%
-5.96%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARVANA CO21Q2 202338.5%
AMAZON COM INC20Q4 202033.8%
SEA LTD19Q3 202360.8%
CARDLYTICS INC18Q3 202326.3%
MEDICINES CO18Q4 201919.8%
ATARA BIOTHERAPEUTICS INC15Q3 202317.9%
CONSTELLATION BRANDS INC14Q4 201611.1%
HERBALIFE NUTRITION LTD13Q1 202124.8%
CLARIVATE PLC11Q4 202124.4%
EXACT SCIENCES CORP11Q2 201924.6%

View Antipodean Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Antipodean Advisors LLC Q2 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oncothyreon Inc.Sold outJanuary 09, 201300.0%

View Antipodean Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16

View Antipodean Advisors LLC's complete filings history.

Compare quarters

Export Antipodean Advisors LLC's holdings